Novartis' Expert Denies Rival Atty's Plagiarism Claim In IP Trial
A computational chemist hired by Novartis testified to a California federal jury Friday that a Daiichi Sankyo subsidiary's drug patents are invalid for being too broad, while defending his credibility against...To view the full article, register now.
Already a subscriber? Click here to view full article